Feb 28, 2021 • 11 hours ago • 3 minute read • 84 Comments
Article content
Canada is being described as a “vaccine pirate” after the latest announcement of COVID vaccine approvals showed we will be getting our doses from a facility funded to provide vaccines for the developing world.
On Friday, Health Canada announced that they had approved two related but distinct products, the AstraZeneca vaccine developed in collaboration with Oxford University and COVISHIELD, a version of the AstraZeneca recipe manufactured by Serum Institute of India.
The problem is that Canada will be getting its doses, starting as early as Wednesday, from the Serum Institute, an organization funded to produce vaccine doses for low- and middle-income countries.
Like the announcement that the Trudeau government will take 1.9 million doses from COVAX, this makes it look like Canada is taking vaccines meant for poorer countries.
In a news release last June announcing the deal that would allow the SII to produce the AstraZeneca vaccine, the company specifically said it was “to supply 1 billion doses for low-and-middle-income countries” In September, a donation from the Bill and Melinda Gates Foundation allowed the program to expand by an extra 100 million doses.
Every single one of which is a dose made in India for developing countries, which Canada poached last week because Trudeau bungled our own procurement.
How many people in other lands will this kill? “Sunny ways” it isn’t. Ashamed to be Canadian today. https://t.co/esfzPL0824
This advertisement has not loaded yet, but your article continues below.
Article content
“This is vaccine manufacturing for the Global South, by the Global South, helping us to ensure no country is left behind when it comes to the race for a COVID-19 vaccine,” said Dr. Seth Berkley, CEO Gavi, the alliance to ensure poor countries have access to vaccines.
Now Canada has found its way to the front of that line.
Procurement Minister Anita Anand confirmed on Friday that of the 3.9 million doses of the AstraZeneca/COVISHIELD vaccines that we will see delivered before the end of June, 2 million will come from the Serum Institute and 1.9 million from COVAX.
The move has led one former Canadian health bureaucrat who now works internationally to accuse the Trudeau government of turning Canada into a “global vaccine pirate.” It’s a view held by many people paying attention to the details of our latest vaccine announcement.
We apologize, but this video has failed to load.
Amir Attaran, a professor with the School of Epidemiology and Public Health at the University of Ottawa, accused the Trudeau government of poaching these doses from developing countries.
“How many people in other lands will this kill? ‘Sunny ways’ it isn’t,” Attaran said on Twitter.
Dr. Srinivas Murthy, an infectious disease specialist with the B.C. Children’s Hospital, said that Canada was taking doses away from LMICs or low and middle-income countries.
“This is much more anger-inducing than the COVAX conversation weeks ago. The Serum Institute of India was funded by CEPI and GAVI to produce vaccines for LMICs. Canada, because of diplomacy and money, is skipping that line and taking doses meant for LMICs,” Dr. Murthy said.
Advertisement
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
When the Trudeau government announced at the beginning of February that we would be taking vaccines from COVAX, the move was blasted by a broad range of organizations including Doctors Without Borders and Oxfam.
“Canada should not be taking the COVAX vaccine from poor nations to alleviate political pressures at home,” Oxfam said at the time.
This is much more anger-inducing than the COVAX conversation weeks ago. The Serum Institute of India was funded by CEPI and GAVI to produce vaccines for LMICs. Canada, because of diplomacy and money, is skipping that line and taking doses meant for LMICs.https://t.co/YmWERXomLjhttps://t.co/9LT8taSHyw
This advertisement has not loaded yet, but your article continues below.
Article content
Yet, that is exactly what Trudeau was doing in early February and it is what he is doing now. Canadians are upset at seeing Americans, Brits, Italians, Serbians and Barbadians vaccinated much fast than we are, and they are rightly blaming the federal government.
Even the record 643,000 doses received across the country last week is less than the Americans use before lunch each day.
Justin Trudeau campaigned on improving Canada’s reputation on the world stage, now we are taking vaccines meant for developing countries. It is nothing short of a national embarrassment.
The Trudeau government owes Canadians an explanation on his latest moves; let’s hope he faces the tough questions he should later this week.
Share this article in your social network
The Toronto Sun Headline News
Sign up to receive daily headline news from the Toronto SUN, a division of Postmedia Network Inc.
By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300
Thanks for signing up!
A welcome email is on its way. If you don’t see it please check your junk folder.
The next issue of The Toronto Sun Headline News will soon be in your inbox.
We encountered an issue signing you up. Please try again
TORONTO – Restaurant Brands International Inc. reported net income of US$357 million for its third quarter, down from US$364 million in the same quarter last year.
The company, which keeps its books in U.S. dollars, says its profit amounted to 79 cents US per diluted share for the quarter ended Sept. 30 compared with 79 cents US per diluted share a year earlier.
Revenue for the parent company of Tim Hortons, Burger King, Popeyes and Firehouse Subs, totalled US$2.29 billion, up from US$1.84 billion in the same quarter last year.
Consolidated comparable sales were up 0.3 per cent.
On an adjusted basis, Restaurant Brands says it earned 93 cents US per diluted share in its latest quarter, up from an adjusted profit of 90 cents US per diluted share a year earlier.
The average analyst estimate had been for a profit of 95 cents US per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
ST. JOHN’S, N.L. – Fortis Inc. reported a third-quarter profit of $420 million, up from $394 million in the same quarter last year.
The electric and gas utility says the profit amounted to 85 cents per share for the quarter ended Sept. 30, up from 81 cents per share a year earlier.
Fortis says the increase was driven by rate base growth across its utilities, and strong earnings in Arizona largely reflecting new customer rates at Tucson Electric Power.
Revenue in the quarter totalled $2.77 billion, up from $2.72 billion in the same quarter last year.
On an adjusted basis, Fortis says it earned 85 cents per share in its latest quarter, up from an adjusted profit of 84 cents per share in the third quarter of 2023.
The average analyst estimate had been for a profit of 82 cents per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
TORONTO – Thomson Reuters reported its third-quarter profit fell compared with a year ago as its revenue rose eight per cent.
The company, which keeps its books in U.S. dollars, says it earned US$301 million or 67 cents US per diluted share for the quarter ended Sept. 30. The result compared with a profit of US$367 million or 80 cents US per diluted share in the same quarter a year earlier.
Revenue for the quarter totalled US$1.72 billion, up from US$1.59 billion a year earlier.
In its outlook, Thomson Reuters says it now expects organic revenue growth of 7.0 per cent for its full year, up from earlier expectations for growth of 6.5 per cent.
On an adjusted basis, Thomson Reuters says it earned 80 cents US per share in its latest quarter, down from an adjusted profit of 82 cents US per share in the same quarter last year.
The average analyst estimate had been for a profit of 76 cents US per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.